Baltimore Female Sexual Dysfunction specialist at OptiHealth Institute treats Baltimore - Washington DC Metro women who want to experience a higher level of libido and sexual satisfaction using the cutting-edge PT141 Peptide Therapy as a safe, natural and non-invasive functional medicine treatment for Baltimore women of all ages!
Eric Nager, M.D. of OptiHealth Institute welcomes you to the new era of women’s sexual wellness! Take control of your pleasure today with PT-141 and join thousands of Baltimore - Washington DC Metro women who have already experienced the joys of a more vibrant sex life. With PT-141 peptide therapy in addition to the latest in functional medicine treatments offered by Eric Nager, M.D. of OptiHealth Institute, you can discover for yourself what it means to feel your best again. For far too long, women have been left behind when it comes to advancements in libido and sexual wellness. But now, with the FDA-approved treatment of Bremelanotide (PT-141) women can take back their sex lives and live happily and healthily. Women’s health specialist, Eric Nager, M.D. offers PT-141 Peptide Therapy to Baltimore women of all ages!
Baltimore Women’s Sexual Wellness specialist, Eric Nager, M.D. offers Bremelanotide (PT-141) Peptide Therapy to Baltimore Women in a safe, caring and compassionate environment. Call (443) 737-4456 Today!
PT-141 Peptide Therapy and Female Sexual Wellness
Baltimore PT141 peptide specialist at OptiHealth Institute treats female sexual dysfunction conditions using PT141 (Bremelanotide) in combination with the latest in functional medicine and will always recommend the most effective treatments for each women’s unique needs and goals. Women’s sexual health specialist at OptiHealth Institute treats every woman as an individual and prioritizes the health, happiness and overall well-being of female sexual wellness patients above all else. It’s time to take charge of your sexual health today and experience the pleasure you deserve!
What is Pt-141 Bremelanotide?
The reality of low sexual desire in women can be an isolating experience. The daily struggle to feel connected with your partner can cause emotional and physical disconnection. But now, there’s a solution that could help you break through these barriers. Bremelanotide is a first-in-class medication designed specifically to treat generalized hypoactive sexual desire disorder (HSDD) in premenopausal women without underlying medical, psychiatric, or relationship problems. With just a single injection, Bremelanotide works quickly—producing results in as little as 45 minutes—to increase your libido and facilitate a more intimate connection with your partner. Help take back your intimate life with Bremelanotide – the only FDA approved (Vyleesi) solution for premenopausal women with generalized HSDD. Get in touch today to find out how this revolutionary medication could change your life.
Unlike other treatments, PT-141 or Bremelanotide works through the nervous system instead of the vascular system, making it a safe and natural way to promote desire. So forget feeling stuck with symptoms of aging – Eric Nager, M.D. of OptiHealth Institute believes you deserve a satisfying sex life just as much as anyone else! With PT-141, you can finally make your sexual dreams come true.
How is bremelanotide administered?
Bremelanotide (PT-141) is a prescription medication used to treat low libido and lack of orgasm in premenopausal women. It is administered via subcutaneous injection into fat deposits in the lower abdomen, stomach area, or thigh 45 minutes prior to anticipated sexual activity. It is recommended to take no more than one dose per 24 hours or no more than 8 doses per month and discontinue use after 8 weeks if there is no improvement in sexual desire. Consult Eric Nager, M.D. of OptiHealth Institute to determine if Bremelanotide (PT-141) is right for you, as it may be offered in combination with other sexual health and functional medicine services.
It is important to speak with Eric Nager, M.D. of OptiHealth Institute prior to using this medication. Eric Nager, M.D. of OptiHealth Institute can help you determine if Bremelanotide (PT-141) is the right treatment for you.